Server was unable to process request. ---> The data types ntext and varchar are incompatible in the equal to operator. Incorrect syntax near ')'. Incorrect syntax near the keyword 'declare'. Khandwala Securities Limited.
NIFTY
149.20  1.59%
 9509.75
S&P BSE SENSEX
448.39  1.48%
 30750.03
Cadila Healthcare Ltd.
NSE : CADILAHC BSE : 532321 ISIN code : INE010B01027
on 25-May-2017
NSE
-13.95    -3.17%
Rs. 426.70
 
Days Low
Rs. 417.2
Days High
Rs. 446.25

Open Rs. 442
 
52 week Low
Rs. 305.05
52 week High
Rs.497.25
 
 
Bid :                 426.80 (104)
Offer :        0.00 (0)
BSE
Rs.426.80
-14.1    -3.2%
on 25-May-2017
BSE
-14.1    -3.2%
Rs. 426.80
 
Days Low
Rs. 417.05
Days High
Rs. 446.7

Open Rs. 442.1
 
52 week Low
Rs. 305
52 week High
Rs.497
 
 
Bid :                 426.80 (104)
Offer :        0.00 (0)
NSE
Rs.426.70
-13.95    -3.17%
 
 
Last Price (Rs.)  426.80 Value  167199766.00
Net Change (Rs.)  -14.10 Best Buy  426.80
Volume  386443 Best Sell  0.00
Prev.Close (Rs.)  440.90 Best Quantity  104
Open (Rs.)  442.00 Sell Quantity  0
High (Rs.)  446.25 52-Week High (Rs.)  497.25
Low (Rs.)  417.20 52-Week Low (Rs.)  305.05
Face Value (Rs.)  1 Market Cap.(Rs/ Mn)  436933.34
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital1024.00 1024.00 1024.00 
Share Capital1024.00 1024.00 1024.00 
Share Capital1024.00 1024.00 1024.00 
Share Capital1024.00 1024.00 1024.00 
Share Capital1024.00 1024.00 1024.00 
Currents Investments1008.00 4583.00 2924.00 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Sun Pharma Inds. 591.80 1419901 89.42 0.00 0.17
Lupin 1137.95 513979 327.23 17.77 0.66
Piramal Enterprises 2694.50 464971 837.79 43.81 0.78
Cipla 504.10 405573 157.30 28.97 0.40
Dr. Reddys Lab 2427.30 402305 699.92 30.57 0.82
 
Mutual Funds Holdings
 
Quarterly Result
(Rs .in millions)Dec 2016Sep 2016Jun 2016
Net Sales11011.0010914.0012717.00
Operating Profit1369.002051.002773.00
PBDT1332.001993.002716.00
Net Profit539.001090.001651.00
More> 
 
Company News
5/23/2017 12:00:00 AM
Zydus Cadila receives final approval for Cyproheptadine Hydrochloride ...
5/22/2017 12:00:00 AM
Updates on Amalgamation/ Merger / Demerger
5/10/2017 12:00:00 AM
Zydus wins Federal Circuit Appeal in generic version of Lialda (Mesala...
More>
 
Ratios
   Earnings Per Share (Rs)19.31 
   Book NAV/Share(Rs)59.94 
   PAT Margin (%)27.73 
   Asset Turnover(x)0.83 
   PER(x)16.41 
   Yield(%)1.01 
   EV/Core EBITDA(x)12.52 
   M Cap / Sales4.61 
   Net Sales Growth(%)33.13 
   PAT Growth(%)55.56 
   Total Debt/Equity(x)0.20 
   Current Ratio(x)1.43 
   Quick Ratio(x)1.15 
   Total Debt/Mcap(x)0.04 
More>